The impact of nanotechnology on myocardial infarction treatment

Nanomedicine

Volumn 7, Issue 2, 2012, Pages 173-175

  Buxton, Denis B ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

diagnostics; myocardial infarction; nanotechnology; regenerative medicine; therapeutic delivery

Indexed keywords

4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; ANGIOTENSIN 1 RECEPTOR; CHEMOKINE RECEPTOR CCR2; FIBROBLAST GROWTH FACTOR 2; N ACETYLGLUCOSAMINE; NANOPARTICLE; PLATELET DERIVED GROWTH FACTOR BB; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; APOPTOSIS; ASSAY; DRUG DELIVERY SYSTEM; ELECTROCARDIOGRAM; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REGENERATIVE MEDICINE; REPERFUSION INJURY; REVIEW;

DIAGNOSTIC IMAGING; HUMANS; MYOCARDIAL INFARCTION; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84857604592     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.184     Document Type: Review

References (15)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics -2011 update: A report from the American Heart Association. Circulation 123, e18-e209 (2011).
2. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 8, 30-41 (2011).
3. Wilson SR, Sabatine MS, Braunwald E, Sloan S, Murphy SA, Morrow DA. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 trial. Am. Heart J. 158, 386-391 (2009).
4. Goluch ED, Nam JM, Georganopoulou DG, et al. A bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab Chip 6, 1293-1299 (2006).
5. Gray WD, Che P, Brown M, Ning X, Murthy N, Davis ME. N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing. J. Cardiovasc. Transl. Res. 4, 631-643 (2011).
6. Dvir T, Bauer M, Schroeder A, et al. Nanoparticles targeting the infarcted heart. Nano Lett. 11, 4411-4414 (2011).
7. Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616 (2009).
8. Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 29, 1005-1010 (2011).
9. Lin YD, Yeh ML, Yang YJ, et al. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation 122(Suppl. 11), S132-S141 (2010).
10. Segers VFM, Lee RT. Local delivery of proteins and the use of self-assembling peptides. Drug Discov.Today. 12, 561-568 (2007).
11. Kim JH, Jung Y, Kim SH, et al. The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. Biomaterials 32, 6080-6088 (2011).
12. Orlova Y, Magome N, Liu L, Chen Y, Agladze K. Electrospun nanofibers as a tool for architecture control in engineered cardiac tissue. Biomaterials 32, 5615-5624 (2011).
13. Dvir T, Timko BP, Brigham MD, et al. Nanowired three-dimensional cardiac patches. Nat. Nanotechnol. 6, 720-725 (2011).
14. Zhang B, Xiao Y, Hsieh A, Thavandiran N, Radisic M. Micro-and nanotechnology in cardiovascular tissue engineering. Nanotechnology 22, 494003 (2011).
15. Kenar H, Kose GT, Toner M, Kaplan DL, Hasirci V. A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials 32, 5320-5329 (2011).